Cidara Therapeutics, Inc.
Methods for preventing and treating pneumocystis infections

Last updated:

Abstract:

The disclosure relates to methods of prophylactic and therapeutic treatments of a Pneumocystis infection (i.e., an infection caused by Pneumocystis jirovecii) in a subject by administering to the subject a compound of any of formulas (I)-(III) (e.g., a salt of Compound 1, or a neutral form thereof). The disclosure also relates to methods of inhibiting the replication of a Pneumocystis spp. The methods of the disclosure can be useful in immunocompromised subjects.

Status:
Grant
Type:

Utility

Filling date:

1 Aug 2019

Issue date:

22 Sep 2020